<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2020</study_start_year><data_sharing_plan>IPD Sharing (as of February 2021): No</data_sharing_plan><condition>Rectal Neoplasms</condition><condition>Rectal Cancer</condition><disease>Rectal Neoplasms</disease><disease>Rectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2366863</full_dataset_link><location>Russia</location><study_start_month>10</study_start_month><keyword>Colorectal disease</keyword><keyword>Total neoadjuvant therapy</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Total Neoadjuvant Therapy in Rectal Cancer Treatment</name><description>This is a randomized, controlled, parallel study to determine the efficiency and safety of total neoadjuvant therapy in rectal cancer treatment.</description><dates><creation>2020-10-15</creation></dates><accession>2366863</accession><cross_references><ClinicalTrials___gov>NCT04747951</ClinicalTrials___gov></cross_references></HashMap>